News

Net profit of Biogen Pharmachem Industries declined 83.58% to Rs 0.22 crore in the quarter ended June 2026 as against Rs 1.34 crore during the previous quarter ended June 2025. There were no Sales reported in the quarter ended June 2026 and during the previous quarter ended June 2025.Powered by Capital Market - Live News

Biogen Pharmachem Industries will hold a meeting of the Board of Directors of the Company on 5 August 2026.

Net loss of Biogen Pharmachem Industries reported to Rs 0.36 crore in the quarter ended March 2026 as against net profit of Rs 1.18 crore during the previous quarter ended March 2025. There were no Sales reported in the quarter ended March 2026 and during the previous quarter ended March 2025.For the full year,net profit reported to Rs 0.86 crore in the year ended March 2026 as against net loss of Rs 0.29 crore during the previous year ended March 2025. There were no Sales reported in the year ended March 2026 and during the previous year ended March 2025.Powered by Capital Market - Live News

Biogen Pharmachem Industries will hold a meeting of the Board of Directors of the Company on 14 May 2026.

Biogen Pharmachem Industries will hold a meeting of the Board of Directors of the Company on 23 March 2026.Powered by Capital Market - Live News